2012
DOI: 10.1136/gutjnl-2011-300771
|View full text |Cite
|
Sign up to set email alerts
|

Tumour necrosis factor α secretion induces protease activation and acinar cell necrosis in acute experimental pancreatitis in mice

Abstract: The soluble inflammatory cell mediator TNFα directly induces premature protease activation and necrosis in pancreatic acinar cells. This activation depends on calcium and cathepsin-B activity. The findings from the present work further suggest that targeting TNFα, for which pharmaceutical agents are readily available, could be an effective treatment strategy that directly addresses the cellular causes of pancreatitis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
188
0
5

Year Published

2013
2013
2024
2024

Publication Types

Select...
5
4
1

Relationship

1
9

Authors

Journals

citations
Cited by 187 publications
(194 citation statements)
references
References 50 publications
1
188
0
5
Order By: Relevance
“…The two phenomena appear to be independent and mediated by different factors (62)(63)(64). Awla et al (61) use the pharmacologic inhibitor CsA to demonstrate the importance of calcineurin pathways.…”
Section: Discussionmentioning
confidence: 99%
“…The two phenomena appear to be independent and mediated by different factors (62)(63)(64). Awla et al (61) use the pharmacologic inhibitor CsA to demonstrate the importance of calcineurin pathways.…”
Section: Discussionmentioning
confidence: 99%
“…One is the observation that the autosomal dominant inherited form of pancreatitis is associated with germline mutations in the cationic trypsinogen (PRSS1) gene (4,5) and that most inherited risk factors for pancreatitis involve alterations in digestive proteases (6,7). The other is the fact that the mechanism of premature intracellular protease activation and its contributing biochemical and immunological factors are increasingly better understood (8,9) and have parallels in experimental models that mimic human pancreatitis (10 -12), allowing the conclusion that CTSB 3 is a critical intracellular player. CTSB is a lysosomal hydrolase that has long been shown to activate trypsinogen in vitro (13) but has also been found to be involved in the pathophysiology of experimental models of pancreatitis (14 -16).…”
mentioning
confidence: 99%
“…Therapies for AP currently under study aim to inhibit proinflammatory pathways, such as TNF-α, with neutralizing antibodies, or up-regulate anti-inflammatory cytokines such as IL-10 or IL-22 (Feng et al, 2012;Xue et al, 2012;Sendler et al, 2013). Elevation of anti-inflammatory cytokines as a therapy should be approached with caution though, as up-regulation of cytokines that reduce AP might also predispose to CP.…”
Section: Cytokines and Pancreatitismentioning
confidence: 99%